Preventing cervical cancer in low-resource settings: Building a case for the possible

International Journal of Gynecology and Obstetrics

Volumn 89, Issue SUPPL. 2, 2005, Pages

  Pollack, A E ^a   Tsu, V D ^b  

^a ENGENDERHEALTH   (United States)

^b PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

CANCER MORTALITY; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; CYTOLOGY; DEVELOPING COUNTRY; EDITORIAL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

EID: 16844382217     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2005.01.014     Document Type: Editorial

References (8)

1. M. O'Down, and E. Phillipp The speculum The history of obstetrics and gynaecology 1994 Parthenon Publishing Group New York 397 401
2. A. Singer, and J. Monaghan The histology of lower anogenital tract neoplasia Lower genital tract precancer: Colposcopy, pathology, and treatment 1994 Blackwell Scientific Boston
3. International Agency for Research on Cancer (IARC) Cervix Cancer Screening IARC handbooks of cancer prevention vol. 10 2004 IARC Press Lyon, France
4. M. Lewis Situational analysis of cervical cancer in Latin America and the Caribbean 2004 Pan American Health Organization Washington, DC
5. J. Ferlay, F. Bray, P. Pisani, and D. Parkin Cancer incidence, mortality and prevalence worldwide 2001 IARC Press Lyon, France
6. S.J. Goldie, M. Kohli, D. Grima, M.C. Weinstein, T.C. Wright, and F.X. Bosch Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine J. Natl. Cancer Inst. 96 8 2004 604 615
7. J.P. Hughes, G.P. Garnett, and L. Koutsky The theoretical population-level impact of a prophylactic human papillomavirus vaccine Epidemiology 13 6 2002 631 639
8. S.L. Kulasingam, and E.R. Myers Potential health and economic impact of adding a human papillomavirus vaccine to screening programs JAMA 290 6 2003 781 789